Flow Space on MSN1d
5 Factors That Make It More Likely You'll Develop Heart DiseaseHeart disease has long been considered a man's disease, but the reality is far more complex. Women face unique risks, ...
A recent Brazilian study published in Nature Cardiovascular Research has highlighted promising pathways for preventing and ...
Eko Health has been advancing the use of artificial intelligence to help providers detect the early signs of disease, ...
Akura Medical begins patient enrollment in QUADRA-PE study of Katana Thrombectomy System to treat acute pulmonary embolism: Los Gatos, California Thursday, February 6, 2025, 18:00 ...
COVID-19 accelerates the progression of atherosclerotic plaques, increasing coronary inflammation and the risk of high-risk ...
In a trial, Gossamer Bio's PAH treatment candidate seralutinib reduced the resistance blood faces moving into the lungs over ...
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
Akura Medical, Inc., a privately held portfolio company of Shifamed LLC that is developing treatments for venous thromboembolis ...
Akura Medical, a Shifamed portfolio company focused on reshaping the landscape of venous thromboembolism (VTE) care, announced today the first patient enrollment in the QUADRA-PE study (NCT06672510) ...
Compression socks help improve blood flow and reduce swelling in the feet and ankles. Here’s everything to know to decide if ...
Merck plans to stop a late-stage study testing its drug to treat pulmonary arterial hypertension (PAH) ahead of time based on ...
Men with PAH had a larger right heart size and worse survival than women, independent of body size and functional status, a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback